| Cemiplimab studied in …STUDIED_INderived191 of 191show fewer |
|---|
| → studied in | NCT07195734Phase 2 · recruiting Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · 191 trials list this drug (134 active) | — | — | Malignant Lip and Oral Cavity Neoplasm,Malignant Laryngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384807Phase 1/Phase 2 · recruiting A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931717Phase 3 · recruiting A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564340Phase 1/Phase 2 · recruiting Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers · 191 trials list this drug (134 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm,Malignant Endometrial Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04253964Phase 2 · recruiting Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246916Phase 3 · recruiting A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · 191 trials list this drug (134 active) | — | — | Malignant Lip and Oral Cavity Neoplasm,Head and Neck Squamous Cell Carcinoma,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07360743Phase 2 · recruiting Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590326Phase 1/Phase 2 · recruiting A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab · 191 trials list this drug (134 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05363319recruiting An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387084Phase 1 · active not recruiting Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy · 191 trials list this drug (134 active) | — | — | Malignant Skin Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543071Phase 2 · active not recruiting Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma · 191 trials list this drug (134 active) | — | — | Adenocarcinoma,Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05259709Phase 1 · recruiting A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab · 191 trials list this drug (134 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05878288Phase 2 · active not recruiting Deep sequencIng in Cutaneous Squamous CEll caRciNomas · 191 trials list this drug (134 active) | — | — | Neoplasm,Skin Carcinoma,Skin Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06900595Phase 2 · recruiting Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer · 191 trials list this drug (134 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694871Phase 2 · active not recruiting Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma · 191 trials list this drug (134 active) | — | — | Dedifferentiated Liposarcoma,Soft Tissue Sarcoma of the Trunk and Extremities | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208944Phase 2 · active not recruiting THIO Sequenced With Cemiplimab in Advanced NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06585410Phase 3 · recruiting Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943664Phase 2 · withdrawn Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04428671Phase 1 · active not recruiting Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05882734Phase 1/Phase 2 · completed Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787612Phase 2 · recruiting Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer · 191 trials list this drug (134 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07527325Phase 2 · not yet recruiting Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06269133active not recruiting Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Participants · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147231Phase 1/Phase 2 · recruiting Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer · 191 trials list this drug (134 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808515Phase 2 · not yet recruiting A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC) · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902376Phase 1 · recruiting XL092 and Cemiplimab in BRAF WT Thyroid Cancer · 191 trials list this drug (134 active) | — | — | Thyroid Gland Neoplasm,Malignant Thyroid Gland Neoplasm,Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808138Phase 2 · not yet recruiting RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188896Phase 2 · recruiting A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) · 191 trials list this drug (134 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281417Phase 2 · recruiting Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Malignant Sinonasal Neoplasm,Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07058012Phase 2 · recruiting A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) · 191 trials list this drug (134 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414992Phase 2 · withdrawn A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · 191 trials list this drug (134 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Adult Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,Head and Neck Cutaneous Squamous Cell Carcinoma,Skin Acantholytic Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06385262Phase 2 · suspended TOP 2301: Neoadjuvant Chemo for NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465329Phase 2 · active not recruiting A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06769698Phase 2 · recruiting A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05317858Phase 3 · recruiting Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets · 191 trials list this drug (134 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07050186Phase 2 · recruiting Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma · 191 trials list this drug (134 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06743581NA · recruiting Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06826768Phase 1 · recruiting A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC · 191 trials list this drug (134 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06162572Phase 1/Phase 2 · active not recruiting Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06656598Phase 2 · recruiting Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234058Phase 2 · recruiting Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma · 191 trials list this drug (134 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650266Phase 1 · not yet recruiting A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma · 191 trials list this drug (134 active) | — | — | Malignant Nasopharyngeal Neoplasm,Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161441Phase 2 · active not recruiting A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746388Phase 2 · not yet recruiting Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444880Phase 2 · active not recruiting Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies · 191 trials list this drug (134 active) | — | — | Sarcoma,Epithelioid Sarcoma,Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06449313Phase 2 · recruiting Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669989Phase 2 · enrolling by invitation International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab · 191 trials list this drug (134 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448026Phase 2 · recruiting Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Oral Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470489Phase 2 · not yet recruiting Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer · 191 trials list this drug (134 active) | — | — | Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04243616Phase 2 · active not recruiting Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer · 191 trials list this drug (134 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142189Phase 1 · recruiting Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720167Phase 2 · not yet recruiting Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04722523Phase 1 · recruiting A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer · 191 trials list this drug (134 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088771Phase 1/Phase 2 · recruiting Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281768Phase 2 · recruiting Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer · 191 trials list this drug (134 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715734Phase 2 · not yet recruiting Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03565783Phase 2 · active not recruiting Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery · 191 trials list this drug (134 active) | — | — | Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179315Phase 2 · recruiting A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment · 191 trials list this drug (134 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800015Phase 2/Phase 3 · active not recruiting A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07450183Phase 2 · not yet recruiting Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03972657Phase 1/Phase 2 · recruiting A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors · 191 trials list this drug (134 active) | — | — | Clear Cell Renal Cell Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651593Phase 2 · recruiting Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors · 191 trials list this drug (134 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06874335Phase 1 · recruiting A Phase 1 Study of BHV-1530 in Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291105Phase 2 · active not recruiting Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients · 191 trials list this drug (134 active) | — | — | Melanoma,Head and Neck Squamous Cell Carcinoma,Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05137054Phase 1 · recruiting A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments · 191 trials list this drug (134 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05608291Phase 3 · active not recruiting A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04626635Phase 1/Phase 2 · active not recruiting A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers · 191 trials list this drug (134 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989946Phase 1/Phase 2 · active not recruiting Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer · 191 trials list this drug (134 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05064085Phase 1 · completed Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer · 191 trials list this drug (134 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05785767Phase 2/Phase 3 · active not recruiting A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06508463Phase 1 · recruiting Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma · 191 trials list this drug (134 active) | — | — | Anaplastic Large Cell Lymphoma,Mycosis Fungoides,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412198Phase 1/Phase 2 · recruiting A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations · 191 trials list this drug (134 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03088540Phase 3 · completed Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862650Phase 2 · active not recruiting Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck · 191 trials list this drug (134 active) | — | — | Malignant Lip and Oral Cavity Neoplasm,Head and Neck Squamous Cell Carcinoma,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975152Phase 1 · recruiting Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma,Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06219317Phase 2 · active not recruiting Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03294083Phase 1/Phase 2 · completed A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07422363Phase 1 · not yet recruiting Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma · 191 trials list this drug (134 active) | — | — | Glioblastoma, IDH-Wildtype,Gliosarcoma,WHO Grade 4 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017820Phase 1 · recruiting A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma · 191 trials list this drug (134 active) | — | — | Histiocytic and Dendritic Cell Neoplasm,Anaplastic Large Cell Lymphoma,B-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05929664Phase 2 · suspended Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04916002Phase 2 · terminated A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma,Lung Non-Small Cell Carcinoma,Skin Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02651662Phase 1 · completed A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies · 191 trials list this drug (134 active) | — | — | B-Cell Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620548Phase 2 · not yet recruiting Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas · 191 trials list this drug (134 active) | — | — | Glioblastoma,Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315701Phase 2 · active not recruiting A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer · 191 trials list this drug (134 active) | — | — | Malignant Skin Neoplasm,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07404332Phase 1 · recruiting 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors · 191 trials list this drug (134 active) | — | — | Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855212Phase 2 · active not recruiting Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860815Phase 2 · recruiting Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer · 191 trials list this drug (134 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03409614Phase 3 · completed Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05574101Phase 2 · active not recruiting A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer · 191 trials list this drug (134 active) | — | — | Malignant Skin Neoplasm,Squamous Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06594991Phase 2 · recruiting A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042379Phase 2 · recruiting I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer · 191 trials list this drug (134 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557591Phase 2 · active not recruiting A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205836Phase 2 · recruiting Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer · 191 trials list this drug (134 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616584Phase 2/Phase 3 · recruiting Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07567469Phase 1/Phase 2 · not yet recruiting A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma · 191 trials list this drug (134 active) | — | — | High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03491683Phase 1/Phase 2 · active not recruiting INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) · 191 trials list this drug (134 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05961709Phase 2 · active not recruiting The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer · 191 trials list this drug (134 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06413680Phase 1/Phase 2 · recruiting A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body · 191 trials list this drug (134 active) | — | — | Solid Neoplasm,Melanoma,Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04763616Phase 2 · completed Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05352672Phase 3 · active not recruiting Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06623656Phase 2 · recruiting Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05704634Phase 1 · active not recruiting A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer. · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020065Phase 2 · recruiting Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06865339Phase 2 · recruiting Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03916627Phase 2 · active not recruiting Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma,Hepatocellular Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07511036Phase 2 · not yet recruiting PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07001618Phase 2 · recruiting Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03969004Phase 3 · active not recruiting Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418724Phase 2 · not yet recruiting Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05401786Phase 2 · active not recruiting Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06981325Phase 2 · recruiting Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06171750Phase 1 · recruiting Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699602Phase 2 · recruiting A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04988074Phase 2 · recruiting Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca · 191 trials list this drug (134 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223541Phase 2 · recruiting Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07433673Phase 2 · recruiting Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) · 191 trials list this drug (134 active) | — | — | Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06918132Phase 2 · recruiting Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07418931Phase 2 · not yet recruiting A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233139Phase 1 · active not recruiting Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06731270Phase 2 · recruiting Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190951Phase 2 · active not recruiting A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04913220Phase 1/Phase 2 · terminated A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) · 191 trials list this drug (134 active) | — | — | Melanoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06469281Phase 1 · recruiting A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers · 191 trials list this drug (134 active) | — | — | Primary Peritoneal Carcinoma,Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03889912Phase 1 · completed Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346196Phase 2 · not yet recruiting A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · 191 trials list this drug (134 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06908304Phase 3 · recruiting A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526899Phase 2 · completed A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022029Phase 1 · recruiting A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Skin Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04154943Phase 2 · completed Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07274384Phase 2 · not yet recruiting Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121180Phase 2 · recruiting Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma · 191 trials list this drug (134 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07251413Phase 1/Phase 2 · recruiting Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132191approved for marketing Expanded Access Use of Cemiplimab in Patients With Solid Tumors · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma,Lung Non-Small Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06917573Phase 2 · recruiting PALACE: Cemiplimab Trial According to ctDNA Levels · 191 trials list this drug (134 active) | — | — | Respiratory System Neoplasm,Thoracic Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052852Phase 1 · terminated Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies · 191 trials list this drug (134 active) | — | — | Malignant Head and Neck Neoplasm,Melanoma,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04982224Phase 1 · terminated Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04826393Phase 1 · completed ASP8374 + Cemiplimab in Recurrent Glioma · 191 trials list this drug (134 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03836105completed CemiplimAb Survivorship Epidemiology · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085572Phase 2 · recruiting Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer · 191 trials list this drug (134 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528769Phase 2 · recruiting Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma · 191 trials list this drug (134 active) | — | — | Sarcoma,Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064330recruiting Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab. · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04646005Phase 2 · completed Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy · 191 trials list this drug (134 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571708Phase 2 · recruiting Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) · 191 trials list this drug (134 active) | — | — | Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05259696Phase 1/Phase 2 · completed Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm,Malignant Head and Neck Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101822Phase 2 · not yet recruiting A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER · 191 trials list this drug (134 active) | — | — | Malignant Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101848Phase 2 · not yet recruiting A PHASE II, RANDOMIZED TRIAL TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT VULVAR CANCER · 191 trials list this drug (134 active) | — | — | Malignant Vulvar Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538988Phase 1/Phase 2 · withdrawn BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma · 191 trials list this drug (134 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305795Phase 1/Phase 2 · active not recruiting An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706715Phase 1/Phase 2 · active not recruiting LAG3 PET Imaging in Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760498Phase 2 · completed Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05840770Phase 2 · withdrawn Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03951831Phase 2 · active not recruiting REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339062Phase 1/Phase 2 · completed Cemiplimab in AlloSCT/SOT Recipients With CSCC · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04006119Phase 2 · terminated Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma · 191 trials list this drug (134 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132636Phase 2 · completed PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257267Phase 3 · completed Study of Cemiplimab in Adults With Cervical Cancer · 191 trials list this drug (134 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03690869Phase 1/Phase 2 · terminated REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma · 191 trials list this drug (134 active) | — | — | Solid Neoplasm,Central Nervous System Neoplasm,Diffuse Intrinsic Pontine Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04382898Phase 1/Phase 2 · terminated PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) · 191 trials list this drug (134 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04632433Phase 2 · active not recruiting Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04465487Phase 1 · terminated Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05662397Phase 1/Phase 2 · active not recruiting A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04050436Phase 2 · active not recruiting Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06090266Phase 1/Phase 2 · recruiting A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Cutaneous Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05376553Phase 1 · enrolling by invitation Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04873375Phase 2 · completed Cemiplimab for Secondary Angiosarcomas · 191 trials list this drug (134 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05501665Phase 1/Phase 2 · recruiting Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer · 191 trials list this drug (134 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532149recruiting ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04679480Phase 2 · unknown Anti-PD1-antibody and Pulsed HHI for Advanced BCC · 191 trials list this drug (134 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384820Phase 2 · withdrawn Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03005782Phase 1 · completed Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04177810Phase 2 · completed Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer · 191 trials list this drug (134 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03669718Phase 2 · unknown A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC · 191 trials list this drug (134 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05094804Phase 1/Phase 2 · unknown A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535023Phase 2 · withdrawn Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma,Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729725Phase 1 · terminated SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL · 191 trials list this drug (134 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05729139Phase 1 · withdrawn Cemiplimab/Peg-Interferon-α in Advanced CSCC · 191 trials list this drug (134 active) | — | — | Squamous Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05302297completed Comparative Efficacy of Cemiplimab to Historical Standard of Care in France · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242173Phase 2 · terminated Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma,Head and Neck Cutaneous Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04831450Phase 2 · withdrawn Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) · 191 trials list this drug (134 active) | — | — | Head and Neck Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460456Phase 1 · unknown A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03684785Phase 1/Phase 2 · terminated Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04373083Phase 2 · withdrawn Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma · 191 trials list this drug (134 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03002376Phase 1 · completed An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1) · 191 trials list this drug (134 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03198130Phase 1 · completed An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1) · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580694Phase 1 · terminated Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) · 191 trials list this drug (134 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02383212Phase 1 · completed Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies · 191 trials list this drug (134 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03492489no longer available Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma · 191 trials list this drug (134 active) | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520245Phase 1 · withdrawn Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study · 191 trials list this drug (134 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |